DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Nexavar (Sorafenib) - News

 
 



News related to Nexavar (Sorafenib) and/or conditions it is approved for

FDA Approves Cabozantinib for Renal Cell Carcinoma
Source: Medscape Hematology-Oncology Headlines [2016.04.26]
As a second-line therapy for advanced disease, it has recently been shown to improve survival. But is it a better choice than nivolumab?
FDA Approvals

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015